Anaesthesia makes up the largest hospital speciality and has a huge role to play in nearly every aspect of any hospital from operating theatres to accident and emergency, to the labour ward, and to intensive care. Our research ranges from basic molecular research into mechanisms of anaesthesia to investigating the clinical impact of novel anaesthetic agents.
Our research covers the entirety of patient’s perioperative journey and through this, we aim to deliver the greatest impact. The section has been pioneering in the development of novel technologies to facilitate the delivery of anaesthetic agents and has also made pivotal in-roads into the mechanism of action of anaesthetic agents and their wider application to other diseases (such as their protective roles in brain injury and in cancer).
@article{Sanders:2005:10.1016/j.bpa.2005.01.005,
author = {Sanders, RD and Ma, D and Maze, M},
doi = {10.1016/j.bpa.2005.01.005},
journal = {Best Pract Res Clin Anaesthesiol},
pages = {461--474},
title = {Anaesthesia induced neuroprotection.},
url = {http://dx.doi.org/10.1016/j.bpa.2005.01.005},
volume = {19},
year = {2005}
}
TY - JOUR
AB - Anaesthetic agents display remarkable neuroprotective potential; here, we describe the evidence supporting its use and highlight areas for future development of the field. In particular the application of isoflurane and/or xenon as inhalational neuroprotectants is advocated and evidence for the neuroprotection provided by barbiturates and suppression of cerebral metabolic rate is discussed.
AU - Sanders,RD
AU - Ma,D
AU - Maze,M
DO - 10.1016/j.bpa.2005.01.005
EP - 474
PY - 2005///
SN - 1753-3740
SP - 461
TI - Anaesthesia induced neuroprotection.
T2 - Best Pract Res Clin Anaesthesiol
UR - http://dx.doi.org/10.1016/j.bpa.2005.01.005
UR - https://www.ncbi.nlm.nih.gov/pubmed/16013694
VL - 19
ER -